SCHEMBL13680207

SCHEMBL13680207

C=C(Nc1cccc(Sc2ncnc3ccc(OC)cc23)c1)Nc1cc(C(C)(C)C)on1

nearest known ligand 0.82

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BRAF P15056 19/20 0.82
RAF1 P04049 14/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1012223 0.90 BRAF (1.00) BRAFRAF1
SCHEMBL13680206 0.89 BRAF (0.81) BRAFRAF1
SCHEMBL16692933 0.84 BRAF (0.82) BRAFRAF1
SCHEMBL1012194 0.83 BRAF (1.00) BRAFRAF1
SCHEMBL13680221 0.82 BRAF (0.87) BRAFRAF1
SCHEMBL1012324 0.82 BRAF (1.00) BRAFRAF1
SCHEMBL1013114 0.79 BRAF (1.00) BRAFRAF1
SCHEMBL18676545 0.79 BRAF (0.77) BRAFRAF1
SCHEMBL1013249 0.75 BRAF (1.00) BRAFRAF1
SCHEMBL1011886 0.75 BRAF (1.00) BRAFRAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2268623-B1 QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORP (US) 2015-05-06 EP disclosed
WO-2009117080-A1 QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATON (US) 2009-09-24 WO disclosed